Omeprazole Noridem (Omeprazole Sodium)

Omeprazole Noridem is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion.
• Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates.
• NSAID‑associated ulcer prevention: lowers risk of ulcer development in high‑risk patients.

• Omeprazole Sodium irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acidity, allowing mucosal healing and symptom control.

Adverse reactions to Omeprazole Noridem are generally mild to moderate and vary in frequency.

Common Side Effects

• Headache: mild, transient headache.
• Diarrhoea: loose stools, often self‑limiting.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis, requires medical attention.
• Acute interstitial nephritis: sudden kidney inflammation.
• Hypomagnesemia: low magnesium levels, may cause muscle cramps.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Hepatic dysfunction: elevated liver enzymes.
• Fracture risk: possible reduction in bone mineral density with long‑term use.

When using Omeprazole Noridem, consider the following precautions:

• Assess renal function: adjust use in severe renal impairment.
• Evaluate hepatic status: use with caution in liver disease.
• Review long‑term therapy: monitor for bone density loss.
• Pregnancy and lactation: weigh benefits against potential risks.
• Drug interactions: check concomitant medications for possible interactions.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole Noridem can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atorvastatin: increased statin exposure, higher risk of myopathy.
• Methotrexate: elevated levels, potential toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: possible alteration of INR, monitor coagulation.
• Digoxin: modest increase in serum concentration.
• Diazepam: enhanced sedation, observe CNS effects.